Congress mandates fertility coverage across all major health insurance systems
H.R. 4648 — Access to Fertility Treatment and Care Act · Filed by Rosa DeLauro (D-CT) · 4 cosponsors · Introduced Jul 23, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill requires health insurance plans and government health programs (Medicare, Medicaid, TRICARE, VA, federal employee plans) to cover fertility treatments—including egg/sperm preservation, artificial insemination, IVF, genetic testing, and related medications—if they already cover childbirth. Plans cannot charge higher copays or deductibles for fertility care than for other medical services, and cannot penalize doctors for providing it or discourage patients from seeking it.
Why we flagged it
The bill's core function is to mandate fertility treatment coverage across all major U.S. health insurance systems. It is a straightforward healthcare access expansion, not a tax measure, appropriation, or regulatory carve-out.
What the text implies
- Fertility coverage mandate may increase insurance premiums for all enrollees, including those who do not use fertility services, creating a cross-subsidy that some may view as unfair.
- The bill allows plans to negotiate reimbursement rates with providers, potentially creating two-tier fertility care: high-reimbursement facilities vs. low-reimbursement clinics, affecting access quality.
The full analysis lists 5 implications of this text.
Who stands to gain
fertility clinics and reproductive medicine practices; pharmaceutical companies (fertility medications); genetic testing laboratories